VN March 2021
Vetnuus | Maart 2021 36 Recent Clinically Relevant Research from Around theWorld DOGS Pituitary surgery: Changing the paradigm in veterinary medicine in the United States In this article, Rachel Rivenburg and colleagues from Idaho and Washington State discuss the management of pituitary-dependent hyperadrenocorticism and hypersomatropism in dogs. Medical management is currently the most common treatment for these conditions in veterinary medicine. Medical management does not provide a cure for either disease process, and rarely is pituitary imagingapartofinitialdiagnostics.Earlypituitaryimaginginanimals with clinically functional pituitary tumours provides a baseline assessment, allows monitoring of tumour changes, and permits radiation and surgical planning. Surgery is the only treatment for pituitary tumours that has curative intent and allows for a definitive diagnosis. Surgical removal of pituitary tumours via transsphenoidal hypophysectomy is an effective treatment for clinical pituitary tumours in patients exhibiting endocrine abnormalities associated with pituitary-dependent hyperadrenocorticism and hypersomatotropism. Surgery, however, is rarely pursued until patients have failed medical management, and often not until they are showing neurologic signs, making surgical success challenging. It is well documented that dogs surgically treatedwhen the pituitary mass is small have a lower mortality, a lower recurrence rate, and a longer survival than those with larger pituitary masses. Providing owners with the option of early pituitary imaging in addition to medical, surgical, and radiation treatment options should be the standard of care for animals diagnosed with pituitary-dependent hyperadrenocorticism or hypersomatotropism. v (Source: https://www.aaha.org) This study by A. Pecile and colleagues explored some clinical features of 50 dogs affected by at least one malignant mammary tumour. Canine mammary tumours represent a hard-prognostic task for veterinary clinicians. TNM staging and grading systems refer to a single tumour. Significant limits come to light when these systems are applied to multiple mammary tumours due to the arbitrary criterion in determining which single tumour is representative of the patient's prognosis. Clinical features and staging, together with histological classification and grading, have been related to disease-free survival (DFS) with the purpose to evaluate their impact on prognosis. The prognosis was worse in 10-11-year-old dogs (P < 0.05), in dogs affected by complex carcinoma (P<0.05), and inpatients assigned toPeñagrade I (P<0.05).Thebodyweightwasnot linearly related toDFS (P<0.01), and patients with a low number of neoformations (n ≤ 2) showed a better prognosis than dogs with 3–5 tumours (P < 0.05). Both the average and the total size of malignant tumours were related to DFS (P < 0.05). Dogs assigned with stage I had the best DFS (P < 0.05). In conclusion, the Peña grade I alone would not seem to guarantee a favourable prognosis when applied to mammary tumours in dogs affected by multiple simultaneous presentations. Different characteristics, besides tumour grading, such as tumour immunophenotype and expression of hormonal receptors, could in the future, contribute to elucidate the clinical behaviour of multiple caninemammary tumours. v (Source: www.sciencedirect.com ) Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=